Beam Therapeutics Inc (BEAM)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -806.578 | -138.507 | -56.352 | -64.034 | -38.485 | -20.531 | -9.461 |
Return on Equity (%) | 205.255 | 184.99 | 57.166 | -875.417 | -69.13 | -37.058 | -15.457 |
Return on Invested Capital (%) | 374.08 | -71.458 | -69.952 | -85.593 | -75.485 | -42.095 | -21.055 |
Operating Margin (%) | N/A | N/A | -434105.556 | -810800 | -714.893 | -427.081 | -34.725 |
Net Profit Margin (%) | N/A | N/A | -505777.778 | -810800 | -714.91 | -474.537 | -35.087 |
Book Value Per Share | -1.915 | 5.37 | 13.779 | 4.289 | 12.089 | 10.725 | 12.04 |
Earnings Per Share | -4.435 | -4.701 | -12.427 | -3.399 | -5.42 | -4.227 | -1.626 |
Cash Per Share | 0.87 | 5.868 | 5.081 | 2.832 | 8.188 | 3.404 | 5.348 |
Working Capital Per Share | -2.073 | 4.916 | 8.928 | 3.598 | 15.493 | 12.711 | 12.337 |
Operating Profit Per Share | N/A | N/A | 0.002 | N/A | 0.758 | 0.891 | 4.634 |
EBIT Per Share | -3.664 | -4.678 | -10.692 | -3.399 | -5.42 | -3.804 | -1.609 |
EBITDA Per Share | -3.664 | -4.678 | -10.692 | -3.399 | -5.42 | -3.804 | -1.609 |
Free Cash Flow Per Share | -4.282 | -4.201 | -11.196 | -3.196 | -4.844 | -3.718 | -1.458 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,18M | 24,96M | 7,33M | 57,25M | 68,39M | 68,39M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 68,39M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -398.463 | N/A | N/A | N/A | -1331.565 | N/A | N/A |
Net Profit Margin (%) | N/A | -398.463 | N/A | N/A | N/A | -1331.565 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,94B |
Ratio cours/bénéfice | -15,22 |
Ratio prix/ventes | 5,34 |
Ratio prix/liquidités | 4,63 |
Ratio prix/valeur comptable | 2,06 |
Rendement de dividende | - |
Actions en circulation | 82,81M |
Volume moyen (1 semaine) | 1,48M |
Volume moyen (1 mois) | 1,16M |
Variation sur 52 semaines | 2,08% |
Plus haut sur 52 semaines | 49,50 |
Plus bas sur 52 semaines | 20,84 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales